Small EJ - Search Results

1

Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results.

Morris MJ, Molina A, Small EJ, de Bono JS, Logothetis CJ, Fizazi K, de Souza P, Kantoff PW, Higano CS, Li J, Kheoh T, Larson SM, Matheny SL, Naini V, Burzykowski T, Griffin TW, Scher HI, Ryan CJ. Morris MJ, et al. Among authors: small ej. J Clin Oncol. 2015 Apr 20;33(12):1356-63. doi: 10.1200/JCO.2014.55.3875. Epub 2015 Jan 26. J Clin Oncol. 2015. PMID: 25624432 Free PMC article. Clinical Trial.

2

Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy.

Timmerman JM, Northfelt DW, Small EJ. Timmerman JM, et al. Among authors: small ej. J Clin Oncol. 1995 Jun;13(6):1391-7. doi: 10.1200/JCO.1995.13.6.1391. J Clin Oncol. 1995. PMID: 7538557

3

Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer.

Small EJ, Srinivas S, Egan B, McMillan A, Rearden TP. Small EJ, et al. J Clin Oncol. 1996 May;14(5):1617-25. doi: 10.1200/JCO.1996.14.5.1617. J Clin Oncol. 1996. PMID: 8622080 Clinical Trial.

4

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.

Small EJ, Vogelzang NJ. Small EJ, et al. J Clin Oncol. 1997 Jan;15(1):382-8. doi: 10.1200/JCO.1997.15.1.382. J Clin Oncol. 1997. PMID: 8996165 Review.

5

Cancer and Leukemia Group B trials for advanced prostate cancer.

Small EJ, Dawson NA, Kantoff PW, Vogelzang NJ. Small EJ, et al. Semin Oncol. 1996 Dec;23(6 Suppl 14):28-31. Semin Oncol. 1996. PMID: 8996582 Review.

6

Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal.

Small EJ, Baron AD, Fippin L, Apodaca D. Small EJ, et al. J Urol. 1997 Apr;157(4):1204-7. J Urol. 1997. PMID: 9120902 Clinical Trial.

7

Prostate cancer.

Small EJ. Small EJ. Curr Opin Oncol. 1997 May;9(3):277-86. doi: 10.1097/00001622-199709030-00011. Curr Opin Oncol. 1997. PMID: 9229151 Review.

8

Pyrazoloacridine for the treatment of hormone-refractory prostate cancer.

Small EJ, Fippin LJ, Whisenant SP. Small EJ, et al. Cancer Invest. 1998;16(7):456-61. doi: 10.3109/07357909809011699. Cancer Invest. 1998. PMID: 9774952 Clinical Trial.

9

Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factor.

Small EJ, Reese DM, Um B, Whisenant S, Dixon SC, Figg WD. Small EJ, et al. Clin Cancer Res. 1999 Jul;5(7):1738-44. Clin Cancer Res. 1999. PMID: 10430077 Clinical Trial.

10

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G, et al. Bubley GJ, et al. Among authors: small ej. J Clin Oncol. 1999 Nov;17(11):3461-7. doi: 10.1200/JCO.1999.17.11.3461. J Clin Oncol. 1999. PMID: 10550143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

464 results

Search Page